These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 16870418)

  • 1. Immunotherapeutic peptide vaccination with leukemia-associated antigens.
    Rusakiewicz S; Molldrem JJ
    Curr Opin Immunol; 2006 Oct; 18(5):599-604. PubMed ID: 16870418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination for leukemia.
    Molldrem JJ
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):13-8. PubMed ID: 16399579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide vaccines for patients with acute myeloid leukemia.
    Schmitt M; Casalegno-Garduño R; Xu X; Schmitt A
    Expert Rev Vaccines; 2009 Oct; 8(10):1415-25. PubMed ID: 19803762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical peptide vaccination trials for leukemia patients.
    Casalegno-Garduño R; Schmitt A; Schmitt M
    Expert Rev Vaccines; 2011 Jun; 10(6):785-99. PubMed ID: 21692700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide vaccines for myeloid leukaemias.
    Dao T; Scheinberg DA
    Best Pract Res Clin Haematol; 2008 Sep; 21(3):391-404. PubMed ID: 18790445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of transient lymphodepletion with busulfan and fludarabine and peptide vaccination in a phase I clinical trial for patients with advanced melanoma.
    Appay V; Voelter V; Rufer N; Reynard S; Jandus C; Gasparini D; Lienard D; Speiser DE; Schneider P; Cerottini JC; Romero P; Leyvraz S
    J Immunother; 2007; 30(2):240-50. PubMed ID: 17471171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer vaccines for patients with acute myeloid leukemia--definition of leukemia-associated antigens and current clinical protocols targeting these antigens.
    Greiner J; Döhner H; Schmitt M
    Haematologica; 2006 Dec; 91(12):1653-61. PubMed ID: 17145602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulation against leukemias and lymphomas: a realistic future treatment?
    Mittal S; Marshall NA; Barker RN; Vickers MA
    Crit Rev Oncol Hematol; 2008 Feb; 65(2):101-8. PubMed ID: 17719232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of vaccination therapy for leukemias.
    Reichardt VL; Brossart P
    Curr Hematol Rep; 2005 Jan; 4(1):73-6. PubMed ID: 15610663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aurora-A kinase: a novel target both for cellular immunotherapy and molecular target therapy against human leukemia.
    Ochi T; Fujiwara H; Yasukawa M
    Expert Opin Ther Targets; 2009 Dec; 13(12):1399-410. PubMed ID: 19821797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multipeptide vaccination in cancer patients.
    Pilla L; Rivoltini L; Patuzzo R; Marrari A; Valdagni R; Parmiani G
    Expert Opin Biol Ther; 2009 Aug; 9(8):1043-55. PubMed ID: 19591629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanoma cancer vaccines and anti-tumor T cell responses.
    Vujanovic L; Butterfield LH
    J Cell Biochem; 2007 Oct; 102(2):301-10. PubMed ID: 17647270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [General principles and first clinical trials of therapeutic vaccines against cancer].
    Baurain JF; Van der Bruggen P; Van den Eynde BJ; Coulie PG; Van Baren N
    Bull Cancer; 2008 Mar; 95(3):327-35. PubMed ID: 18390413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Peptide-based vaccine therapy for cancer patients].
    Yamada A
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():602-7. PubMed ID: 15861717
    [No Abstract]   [Full Text] [Related]  

  • 15. Vaccines in leukemia.
    Lu S; Wieder E; Komanduri K; Ma Q; Molldrem JJ
    Adv Pharmacol; 2004; 51():255-70. PubMed ID: 15464913
    [No Abstract]   [Full Text] [Related]  

  • 16. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemia-associated antigens are critical for the proliferation of acute myeloid leukemia cells.
    Greiner J; Bullinger L; Guinn BA; Döhner H; Schmitt M
    Clin Cancer Res; 2008 Nov; 14(22):7161-6. PubMed ID: 19010831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cell vaccines in acute leukaemia.
    Duncan C; Roddie H
    Best Pract Res Clin Haematol; 2008 Sep; 21(3):521-41. PubMed ID: 18790453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer vaccines: promise for the future or pipe dream?
    Mittendorf EA; Peoples GE; Singletary SE
    Cancer; 2007 Oct; 110(8):1677-86. PubMed ID: 17763371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I clinical study with multiple peptide vaccines in combination with tetanus toxoid and GM-CSF in advanced-stage HLA-A*0201-positive melanoma patients.
    Bins A; Mallo H; Sein J; van den Bogaard C; Nooijen W; Vyth-Dreese F; Nuijen B; de Gast GC; Haanen JB
    J Immunother; 2007; 30(2):234-9. PubMed ID: 17471170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.